ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Kazia Therapeutics Limited

Kazia Therapeutics Limited (KZA)

0.08
0.00
(0.00%)
Closed 08 January 4:00PM

Empower your portfolio: Real-time discussions and actionable trading ideas.

Key stats and details

Current Price
0.08
Bid
0.077
Offer
0.083
Volume
0.00
0.00 Day's Range 0.00
0.00 52 Week Range 0.00
Market Cap
Previous Close
0.08
Open
-
Last Trade
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
0.00
Shares Outstanding
204,338,069
Dividend Yield
-
PE Ratio
0.00
Earnings Per Share (EPS)
-
Revenue
2.31M
Net Profit
-27.32M

About Kazia Therapeutics Limited

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Headquarters
Sydney, New South Wales, Aus
Founded
-
Kazia Therapeutics Limited is listed in the Pharmaceutical Preparations sector of the Australian Stock Exchange with ticker KZA. The last closing price for Kazia Therapeutics was AUD0.08. Over the last year, Kazia Therapeutics shares have traded in a share price range of AUD 0.00 to AUD 0.00.

Kazia Therapeutics currently has 204,338,069 shares in issue. The market capitalisation of Kazia Therapeutics is AUD16.35 million.

KZA Latest News

Kazia Therapeutics Shares Higher Premarket on Key FDA Designation

By Colin Kellaher U.S.-listed shares of Kazia Therapeutics jumped in premarket trading Thursday after the Australian biotechnology company said the U.S. Food and Drug Administration granted a...

Kazia Therapeutics Shares Rise Premarket After Key FDA Designation

By Colin Kellaher U.S.-listed shares of Kazia Therapeutics Ltd. jumped more than 15% in premarket trading Wednesday after the Australian biotechnology company said the U.S. Food and Drug...

Global Coalition for Adaptive Research, Kazia, & Kintara Announce Commencement of Kazia’s Paxalisib & Kintara’s VAL-083 i...

Kazia and Kintara Now Enrolling in GBM AGILE, Registrational Phase 2-3 Adaptive Platform Trial to Evaluate Interventions for Patients With Glioblastoma Kazia’s Paxalisib and Kintara’s VAL-083 to...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000DE
40000000DE
120000000DE
260000000DE
520000000DE
156-1.14-93.44262295081.221.220.0512100120.21647683DE
260-0.52-86.66666666670.61.880.0512032030.63791246DE

KZA - Frequently Asked Questions (FAQ)

What is the current Kazia Therapeutics share price?
The current share price of Kazia Therapeutics is AUD 0.08
How many Kazia Therapeutics shares are in issue?
Kazia Therapeutics has 204,338,069 shares in issue
What is the market cap of Kazia Therapeutics?
The market capitalisation of Kazia Therapeutics is AUD 16.35M
What is the 1 year trading range for Kazia Therapeutics share price?
Kazia Therapeutics has traded in the range of AUD 0.00 to AUD 0.00 during the past year
What is the reporting currency for Kazia Therapeutics?
Kazia Therapeutics reports financial results in AUD
What is the latest annual turnover for Kazia Therapeutics?
The latest annual turnover of Kazia Therapeutics is AUD 2.31M
What is the latest annual profit for Kazia Therapeutics?
The latest annual profit of Kazia Therapeutics is AUD -27.32M
What is the registered address of Kazia Therapeutics?
The registered address for Kazia Therapeutics is THREE INTERNATIONAL TOWERS, LEVEL 24, 300 BARANGAROO TOWERS, SYDNEY, NEW SOUTH WALES, 2000
What is the Kazia Therapeutics website address?
The website address for Kazia Therapeutics is www.kaziatherapeutics.com
Which industry sector does Kazia Therapeutics operate in?
Kazia Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
EM2REagle Mountain Mining Limited
AUD 0.002
(100.00%)
1M
AAUOAntilles Gold Limited
AUD 0.002
(100.00%)
500k
NFLONorfolk Metals Ltd
AUD 0.03
(50.00%)
1.23k
DXBODimerix Limited
AUD 0.345
(50.00%)
833.41k
RGTArgent Biopharma Ltd
AUD 0.25
(47.06%)
335.35k
SPAOSpacetalk Ltd
AUD 0.001
(-66.67%)
1
OSLOBOncoSil Medical Ltd
AUD 0.001
(-50.00%)
840k
NAENew Age Exploration Limited
AUD 0.003
(-25.00%)
195.67k
EXLOElixinol Wellness Limited
AUD 0.003
(-25.00%)
120.37k
GMNGold Mountain Limited
AUD 0.003
(-25.00%)
1.39M
ROGRed Sky Energy Limited
AUD 0.006
(-20.00%)
54.97M
TMGTrigg Minerals Ltd
AUD 0.048
(11.63%)
50.62M
BRNBrainchip Holdings Ltd
AUD 0.35
(-5.41%)
48.85M
GCMGreen Critical Minerals Ltd
AUD 0.019
(15.15%)
42.09M
SYASayona Mining Limited
AUD 0.0275
(1.85%)
35.13M

Discussion

View Full Feed
treasurevalley treasurevalley 2 minutes ago
Oh my poor Dragon even your alter ego can't stand your daily childish rants and seems to have gone missing. The Doc says he will see you for free, but you have to pay for the creams. Hiding you say I hope you buried havnagoatin under that bridge with your other I-HUB names. We bought more DPLS sorry
DPLS
Donotunderstand Donotunderstand 2 minutes ago
DEC 12

scam post
NKLA
Chiron Chiron 2 minutes ago
This should be at .002 - .003, You all need to post it everywhere. 
ASII
DiscoverGold DiscoverGold 2 minutes ago
$SPX 2-year ROC > 45%. Historical stats negative, but skewed pre. and post 1996
By: Nautilus Research | January 6, 2025

• $spx #equities SPX 2-year ROC > 45%. Historical stats negative, but skewed pre. and post 1996.

pbs.twimg.com/media/GgnKbZtWUAAYcvU?for
SPX
955 955 3 minutes ago
Trump certification yesterday is HUGE news for F&F. Civil War averted. SP headed back to $5 and beyond.
splintered sunlight splintered sunlight 3 minutes ago
Yes

Happy I stayed long this one.....
KRTL
crowin crowin 3 minutes ago
Because this is the stinky stock world and these SCAMS are fun to expose.

Slap the ask and just flip and be Happy.

Again make a buck and don't get GREEDY and stuck................
RDAR
Chiron Chiron 3 minutes ago
Great news out today BB, bring in the masses
ASII
SkeBallLarry SkeBallLarry 3 minutes ago
" Mr. Trump to speak *Live* on Real American Voice " ...
Donotunderstand Donotunderstand 3 minutes ago
should we trust it ?

yes

and give them credit
FNMA
Invest-in-America Invest-in-America 3 minutes ago
XTIA: Could we please have a spectacular " VERTICAL-TAKEOFF-&-LANDING " routine today --- PRICE wise that is, which ends up on Planet JUPITER , maybe??? (No puns intended.)
XTIA
max mastiff max mastiff 3 minutes ago
Let’s go 🍺🍺🇺🇸🇺🇸🦍🦍
XTIA
TommyJ7651 TommyJ7651 4 minutes ago
I'm confident they will get it done when the time is right. In all likelyhood It would already have been done but like Dan said in the interview the market has been horrible. I don't want to do a deal at 12 cents a share and neither do Keith. We are going to have to wait for the market to turn aroun
FFMGF
PEACHMAN PEACHMAN 4 minutes ago
Thanks for inviting me to review MGON I like what I see and have the patience to buy and hold longer term
MGON
Ricco79 Ricco79 4 minutes ago
Bill Ackman is good friends with DJT and Elon Musk. Why should Ackman be satisfied with $5 or why should Elon and DJT not give him more.
Think easy!
DJT
Hi_Lo Hi_Lo 4 minutes ago
From CSE which, as opposed to you, is the authority concerning the matter:

https://webfiles.thecse.com/resource/Policy_5_-_Timely_Disclosure_Trading_halts_and_Posting.pdf?pk19wglTGczzzFNIci3V8AB1e_GDbe_G

The onus is the Listed Issuer to ensure appropriate dissemination
TWOH
AMB67 AMB67 4 minutes ago
Vivos' share price should be at least $5 now and at least $60 after IDE approval.

Back in 2018, Sirtex was bought out by an overseas consortium at $25.10 per share. Sirtex ONLY treated ONE indication--liver cancer. RadioGel can treat OVER 18 indications.

It is constant
RDGL
georgie18 georgie18 4 minutes ago
Thanks Pink...🥳
SkeBallLarry SkeBallLarry 4 minutes ago
" Mr. Trump to speak *Live* on Real American Voice " ...
Donotunderstand Donotunderstand 4 minutes ago
sounds very good
thanks

the JPS are not a holding for WORST CASE

if JPS were that certain to hit say PAR=25 - they would be trading 20+ right now - today

the PPS for the JPS suggests there is still more risk than you note

but again
FNMA
DavidLeeRoth DavidLeeRoth 4 minutes ago
That alone puts ASII on track for 51 million in revenue😎 That’s not including what else is coming! ASII WINNING💰
ASII
DiscoverGold DiscoverGold 4 minutes ago
Technical Overbought/Sold Composite
By: Isabelnet | January 7, 2025

• S&P 500

With a reading of 64.39, the US stock market is no more overbought, suggesting a potential shift in investor sentiment and a possible opportunity for market participants to reasses
eagpup eagpup 4 minutes ago
Have they been able to pass the certification or do they need help?
XERI
quester614 quester614 5 minutes ago
OMG so now after years of hearing of Retacell and Nexboard we get Nano technology. LOLOLOLOL This is the new marketing campaign. Announce another change in development.
I guess getting the NFPA 286 test done with the unknown experienced chemist to a whole new developing technology that is th
XERI